Generate Biomedicines’ (NASDAQ:GENB – Get Free Report) lock-up period will expire on Wednesday, August 26th. Generate Biomedicines had issued 25,000,000 shares in its public offering on February 27th. The total size of the offering was $400,000,000 based on an initial share price of $16.00. After the expiration of Generate Biomedicines’ lock-up period, restrictions preventing major […]